A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Study of Repeat Intranodal Injections of Ad-ISF35
- Status
- TERMINATED
- Phase
- PHASE2
Mantel Cell Lymphoma Efficacy of Rituximab Maintenance
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and R-CHOP in B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
- Status
- COMPLETED
- Phase
- PHASE1
Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
- Status
- COMPLETED
- Phase
- PHASE2